Lwowek Slaski, Poland

Katarzyna Joanna Matusiewicz



Average Co-Inventor Count = 7.9

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2007-2011

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Katarzyna Joanna Matusiewicz

Introduction: Katarzyna Joanna Matusiewicz is a prominent inventor based in Lwowek Slaski, Poland. She has made significant strides in the field of medicinal chemistry, securing a total of five patents to her name. Her work primarily focuses on the development of novel pharmaceutical compounds that target specific receptor mechanisms in the body.

Latest Patents: Among her latest innovations are various derivatives of 3-phenylpropionic acid. These compounds are described by intricate formulas where specific groups represent various chemical structures and functionalities. The invention details how these derivatives function as ligands for the PPAR-gamma receptor and outlines their potential use as therapeutic agents in treating conditions mediated by this receptor. The method of treatment involves administering these compounds or their pharmaceutically acceptable salts to mammals in need, aiming for a therapeutically effective outcome.

Career Highlights: Katarzyna has dedicated her career to researching and developing innovative solutions for critical health issues. Her employment at Adamed Sp. z o.o. has provided her with a platform to translate her research into practical applications that can benefit the medical community.

Collaborations: Throughout her career, Katarzyna has collaborated with esteemed colleagues, including Zbigniew Majka and Katarzyna Ewa Rusin. These collaborations have enriched her research and fostered an environment of shared expertise that enhances the innovation process.

Conclusion: Katarzyna Joanna Matusiewicz stands out as a notable inventor in the field of medicinal chemistry. Her innovative contributions and patented inventions not only reflect her expertise but also her commitment to advancing pharmaceutical science. As the industry continues to evolve, her work promises to lead to significant advancements in the treatment of various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…